| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 1 | / | 2012 | ||||||||
| Date of issue: | 2012-04-10 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Access to the ESPI system | |||||||||||
| Official market - legal basis | |||||||||||
| Inne uregulowania | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Management Board of Krka, tovarna zdravil, d.d., Novo mesto (the "Company") hereby informs that on 10 April 2012 the Company obtained access to the Electronic System for Information Transmission (Elektroniczny System Przekazywania Informacji - ESPI). Starting from 10 April 2012, the Company will provide its current and periodical information through ESPI in addition to complying with its reporting obligations through the Slovenian electronic system for the dissemination of the regulated information, SEOnet. Legal basis: § 11.1 of the Rules of using the Electronic System for Information Transmission. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-04-10 | Jo¾e Colariè | President of the Management Board and Chief Executive | |||
